XML 1087 R69.htm IDEA: XBRL DOCUMENT v2.4.0.6
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Investments other than subsidiaries:                        
Fixed maturities $ 445,669       $ 409,460       $ 445,669 $ 409,460    
Limited partnerships 59,954       54,705       59,954 54,705    
Total Investments 617,406       555,925       617,406 555,925    
Cash and cash equivalents 71,549       89,726       71,549 89,726 38,223  
Accounts receivable 83,400       74,094       83,400 74,094    
Other assets 9,818       11,707       9,818 11,707    
Total Assets 983,024       905,294       983,024 905,294    
Liabilities:                        
Total Liabilities 636,312       586,233       636,312 586,233    
Shareholders' equity:                        
Additional paid-in capital 50,275       48,751       50,275 48,751    
Unrealized net gains on investments 35,467       26,592       35,467 26,592    
Retained earnings 258,358       241,325       258,358 241,325 284,346 292,543
Shareholders' equity 346,712       319,061       346,712 319,061 368,735 372,943
Total liabilities and shareholders' equity 983,024       905,294       983,024 905,294    
Revenue:                        
Commissions and service fees                 5,722 6,098 6,911  
Net investment income 2,734 2,343 2,431 2,422 2,652 2,779 2,644 2,653 9,930 10,729 11,335  
Net realized gains (losses) on investments                 9,011 (17,803) 16,485  
Total revenue                 262,124 243,594 249,469  
Expenses:                        
Other                 77,430 73,328 68,704  
Total expenses                 215,518 288,883 214,656  
Income before federal income taxes and equity in undistributed income of subsidiaries                 46,606 (45,289) 34,813  
Federal income tax (benefit)                 14,687 (17,114) 9,798  
Equity in undistributed income (loss) of subsidiaries                 7,052 (21,890) 8,206  
Net income (loss) 4,676 11,687 4,050 11,506 5,498 (12,971) (5,504) (15,198) 31,919 (28,175) 25,015  
Condensed Statements of Cash Flows                        
Net cash provided by operating activities                 55,794 54,284 49,483  
Investing activities:                        
Distributions from limited partnerships                 3,957 757 297  
Net cash provided by (used in) investing activities                 (59,302) 17,295 (62,993)  
Financing activities:                        
Dividends paid to shareholders                 (14,886) (14,846) (33,212)  
Drawing on line of credit                 0 0 8,000  
Net cash used in financing activities                 (14,886) (19,846) (28,212)  
Increase (decrease) in cash and cash equivalents                 (18,177) 51,503 (41,281)  
Cash and cash equivalents at beginning of period       89,726       38,223 89,726 38,223 79,504  
Cash and cash equivalents at end of period 71,549       89,726       71,549 89,726 38,223  
Class A [Member]
                       
Shareholders' equity:                        
Common stock 112       112       112 112    
Class B [Member]
                       
Shareholders' equity:                        
Common stock 524       522       524 522    
Parent Company [Member]
                       
Assets                        
Investment in subsidiaries 362,450       334,328       362,450 334,328    
Due from affiliates 2,719       5,282       2,719 5,282    
Investments other than subsidiaries:                        
Fixed maturities 11,073       11,353       11,073 11,353    
Limited partnerships 255       291       255 291    
Total Investments 11,328       11,644       11,328 11,644    
Cash and cash equivalents 12,134       5,690       12,134 5,690 12,546  
Accounts receivable 8,033       5,890       8,033 5,890    
Other assets 7,225       7,694       7,225 7,694    
Total Assets 403,889       370,528       403,889 370,528    
Liabilities:                        
Premiums payable 29,652       26,367       29,652 26,367    
Deposits from insureds 15,489       13,682       15,489 13,682    
Notes payable to bank 10,000       10,000       10,000 10,000    
Current payable federal income taxes 0       368       0 368    
Other liabilities 2,036       1,050       2,036 1,050    
Total Liabilities 57,177       51,467       57,177 51,467    
Shareholders' equity:                        
Additional paid-in capital 50,275       48,751       50,275 48,751    
Unrealized net gains on investments 35,467       26,592       35,467 26,592    
Retained earnings 260,334       243,084       260,334 243,084    
Shareholders' equity 346,712       319,061       346,712 319,061    
Total liabilities and shareholders' equity 403,889       370,528       403,889 370,528    
Revenue:                        
Commissions and service fees                 20,753 20,974 21,913  
Dividends from subsidiaries                 14,000 14,000 15,000  
Net investment income                 48 100 135  
Net realized gains (losses) on investments                 (49) 67 (100)  
Other                 24 98 284  
Total revenue                 34,776 35,239 37,232  
Expenses:                        
Salary and related items                 15,410 12,281 12,869  
Other                 7,098 5,550 5,615  
Total expenses                 22,508 17,831 18,484  
Income before federal income taxes and equity in undistributed income of subsidiaries                 12,268 17,408 18,748  
Federal income tax (benefit)                 (629) 1,004 1,195  
Net income (loss)                 12,897 16,404 17,553  
Equity in undistributed income (loss) of subsidiaries                 19,022 (44,579) 7,462  
Net income (loss)                 31,919 (28,175) 25,015  
Condensed Statements of Cash Flows                        
Net cash provided by operating activities                 20,735 13,255 32,296  
Investing activities:                        
Purchases of long-term investments                 (8,944) (10,025) (10,889)  
Sales or maturities of long-term investments                 8,902 9,704 9,910  
Decrease in notes receivable from employees                 1,252 106 611  
Distributions from limited partnerships                 0 444 23  
Net disposals (purchases) of property and equipment                 (834) (622) 413  
Other                 228 128 212  
Net cash provided by (used in) investing activities                 604 (265) 280  
Financing activities:                        
Dividends paid to shareholders                 (14,886) (14,846) (33,212)  
Drawing on line of credit                 0 0 8,000  
Repayment on line of credit                 0 (5,000) (3,000)  
Net cash used in financing activities                 (14,886) (19,846) (28,212)  
Increase (decrease) in cash and cash equivalents                 6,453 (6,856) 4,364  
Cash and cash equivalents at beginning of period       5,690       12,546 5,690 12,546 8,182  
Cash and cash equivalents at end of period 12,134       5,690       12,134 5,690 12,546  
Parent Company [Member] | Class A [Member]
                       
Shareholders' equity:                        
Common stock 112       112       112 112    
Parent Company [Member] | Class B [Member]
                       
Shareholders' equity:                        
Common stock $ 524       $ 522       $ 524 $ 522